Death due to COVID-19 | |||||||
---|---|---|---|---|---|---|---|
Exposed | Unexposed | ||||||
Exposure | Age (years) | n total | n events (%) | n total | n events (%) | Crude HR (95% CI) | Adjusted HR (95% CI)a |
Local estrogens alone | 53–62 | 2577 | 0 (0.00) | 12,885 | 0 (0.00) | NE | NE |
63–72 | 2976 | 5 (0.17) | 14,880 | 6 (0.04) | 4.17 (1.27–13.65) | 4.33 (1.31–14.30) | |
> 73 | 4428 | 45 (1.02) | 22,124 | 108 (0.49) | 2.08 (1.47–2.95) | 1.87 (1.32–2.65) | |
Systemic estrogens without progestogens | 53–62 | 2715 | 0 (0.00) | 13,576 | 0 (0.00) | NE | NE |
63–72 | 308 | 0 (0.00) | 1540 | 0 (0.00) | NE | NE | |
> 73 | 166 | 5 (3.01) | 830 | 4 (0.48) | 6.25 (1.68–23.27) | 4.73 (1.22–18.32) | |
Systemic estrogens and progestogens | 53–62 | 7508 | 0 (0.00) | 37,535 | 1 (0.00) | NE | NE |
63–72 | 654 | 0 (0.00) | 3270 | 1 (0.03) | NE | NE | |
> 73 | 190 | 0 (0.00) | 950 | 2 (0.21) | NE | NE | |
Progestogens alone | 53–62 | 8803 | 0 (0.00) | 44,016 | 1 (0.00) | NE | NE |
63–72 | 316 | 0 (0.00) | 1580 | 0 (0.00) | NE | NE | |
> 73 | 204 | 2 (0.98) | 1020 | 6 (0.59) | 1.67 (0.34–8.26) | 2.03 (0.40–10.43) | |
Tibolone alone | 53–62 | 699 | 0 (0.00) | 3495 | 0 (0.00) | NE | NE |
63–72 | 175 | 0 (0.00) | 875 | 0 (0.00) | NE | NE | |
> 73 | 49 | 0 (0.00) | 245 | 0 (0.00) | NE | NE |